Found: 8
Select item for more details and to access through your institution.
Treating compensated liver cirrhosis due to chronic HCV infection genotype 1b with Sofosbuvir+Ledipasvir±Ribavirin- results from a cohort of 139 patients.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S787, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Safety and efficacy of sofosbuvir+ledipasvir±ribavirin in a cohort of 210 patients with decompensated liver cirrhosis and hepatitis C virus infection genotype 1 b-real life data.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S759, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Platelet Activation and Inflammation in Patients with Papillary Thyroid Cancer.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 1959, doi. 10.3390/diagnostics11111959
- By:
- Publication type:
- Article
HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2022, v. 31, n. 2, p. 191, doi. 10.15403/jgld-4187
- By:
- Publication type:
- Article
Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2020, v. 29, n. 4, p. 690, doi. 10.15403/jgld-3148
- By:
- Publication type:
- Article
Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2020, v. 29, n. 3, p. 385, doi. 10.15403/jgld-2448
- By:
- Publication type:
- Article
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
- Published in:
- Journal of Medicine & Life, 2020, v. 13, n. 1, p. 68, doi. 10.25122/jml-2019-0076
- By:
- Publication type:
- Article
Efficacy of treatment with Ombitasvir, Paritaprevir / r + Dasabuvir over 8 versus 12 weeks in chronic HCV hepatitis genotype 1b.
- Published in:
- Romanian Journal of Infectious Diseases / Revista Romana de de Boli Infectioase, 2021, v. 24, n. 1, p. 44, doi. 10.37897/RJID.2021.1.6
- By:
- Publication type:
- Article